The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Trends in the incidence of cancer in the black population of Harare, Zimbabwe 1991–2010
Abstract
Incidence rates of different cancers have been calculated for the black population of Harare, Zimbabwe for a 20‐year period (1991–2010) coinciding with continuing social and lifestyle changes, and the peak, and subsequent wane, of the HIV‐AIDS epidemic. The overall risk of cancer increased during the period in both sexes, with rates of cervix and prostate cancers showing particularly dramatic increases (3.3% and 6.4% annually, respectively). By 2004, prostate cancer had become the most common cancer of men. The incidence of cancer of the esophagus, formerly the most common cancer of men, has remained relatively constant, whereas rates of breast and cervix cancers, the most common malignancies of women, have shown significant increases (4.9% and 3.3% annually, respectively). The incidence of Kaposi sarcoma increased to a maximum around 1998–2000 and then declined in all age groups, and in both sexes The incidence of squamous cell cancers of the conjunctiva is relatively high, with temporal trends similar to those of Kaposi sarcoma. Non‐Hodgkin lymphoma, the fifth most common cancer of men and fourth of women, showed a steady increase in incidence throughout the period (6.7–6.9% annually), although rates in young adults (15–39) have decreased since 2001. Cancer control in Zimbabwe, as elsewhere in sub‐Saharan Africa, involves meeting the challenge of emerging cancers associated with westernization of lifestyles (large bowel, breast and prostate), while the incidence of cancers associated with poverty and infection (liver, cervix and esophagus) shows little decline, and the residual burden of the AIDS‐associated cancers remains significant.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis
Forouzanfar, M. H., Foreman, K. J., Delossantos, A. M., Lozano, R., Lopez, A. D., Murray, C. J. L., & Naghavi, M. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61351-2 · Cited by 1,009
Cited by
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Global cancer statistics, 2012
Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet‐Tieulent, J., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21262 · Cited by 26,850
Global Cancer Incidence and Mortality Rates and Trends—An Update
Torre, L. A., Siegel, R. L., Ward, E. M., & Jemal, A. (2016) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-0578 · Cited by 3,692
Global cancer in women: burden and trends.
Torre, L. A., Islami, F., Siegel, R. L., Ward, E. M., & Jemal, A. (2017) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0858 · Cited by 1,245
The global burden of women's cancers: a grand challenge in global health
Ginsburg, O., Bray, F., Coleman, M. P., Vanderpuye, V., Eniu, A., Kotha, S. R., Sarker, M., Huong, T. T., Allemani, C., Dvaladze, A., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(16)31392-7 · Cited by 1,127
Expanding global access to radiotherapy
Atun, R., Jaffray, D. A., Barton, M. B., Bray, F., Baumann, M., Vikram, B., Hanna, T. P., Knaul, F. M., Lievens, Y., Lui, T. Y. M., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00222-3 · Cited by 1,112
Shrestha, A. D., Neupane, D., Vedsted, P., & Kallestrup, P. (2018) · PubMed · doi:10.22034/apjcp.2018.19.2.319 · Cited by 295
Parkin, D. M., Bray, F., Ferlay, J., & Jemal, A. (2014) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-14-0281 · Cited by 291
Self-citationAzubuike, S. O., Muirhead, C., Hayes, L., & McNally, R. (2018) · World Journal of Surgical Oncology · doi:10.1186/s12957-018-1345-2 · Cited by 273
Patel, P., Rose, C. E., Collins, P. Y., Nuche-Berenguer, B., Sahasrabuddhe, V. V., Peprah, E., Vorkoper, S., Pastakia, S. D., Rausch, D., & Levitt, N. S. (2018) · AIDS · doi:10.1097/qad.0000000000001888 · Cited by 270
Trends in cervical cancer incidence in sub-Saharan Africa
Jedy-Agba, E., Joko, W. Y., Liu, B., Buziba, N. G., Borok, M., Korir, A., Masamba, L., Manraj, S. S., Finesse, A., Wabinga, H., et al. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-0831-9 · Cited by 264
Self-citationBray, F., & Soerjomataram, I. (2015) · Disease Control Priorities, Third Edition (Volume 3): Cancer · doi:10.1596/978-1-4648-0349-9_ch2 · Cited by 209
McCormack, V. A., Menya, D., Munishi, M. O., Dzamalala, C., Gasmelseed, N., Leon Roux, M., Assefa, M., Osano, O., Watts, M., Mwasamwaja, A. O., et al. (2017) · International Journal of Cancer · doi:10.1002/ijc.30292 · Cited by 152
Joko‐Fru, W. Y., Jedy‐Agba, E., Korir, A., Ogunbiyi, O., Dzamalala, C. P., Chokunonga, E., Wabinga, H., Manraj, S., Finesse, A., Somdyala, N., et al. (2020) · International Journal of Cancer · doi:10.1002/ijc.33014 · Cited by 143
Self-citationCancer in Africa 2018: The role of infections
Parkin, D. M., Hämmerl, L., Ferlay, J., & Kantelhardt, E. J. (2020) · International Journal of Cancer · doi:10.1002/ijc.32538 · Cited by 130
Self-citationDhokotera, T., Bohlius, J., Spoerri, A., Egger, M., Ncayiyana, J., Olago, V., Singh, E., & Sengayi, M. (2019) · Infectious Agents and Cancer · doi:10.1186/s13027-019-0228-7 · Cited by 72
Gopal, S., Krysiak, R., Liomba, N. G., Horner, M.-J., Shores, C. G., Alide, N., Kamiza, S., Kampani, C., Chimzimu, F., Fedoriw, Y., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070361 · Cited by 61
Metadata
- Authors
- Chokunonga, E., Borok, M. Z., Chirenje, Z. M., Nyakabau, A. M., & Parkin, D. M.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2013-03-04
- Volume
- 133
- Issue
- 3
- Pages
- 721-729
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W1567352500
- Cited by
- 196
- References
- 1
- FWCI
- 8.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.